AdaptHealth (AHCO) analyst forecast and price target
Analyst forecast
Consensus of 7 analyst ratings
Based on 5 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Baird | Maintained | Outperform | $9.00 from $10.00 | Sep 17, 2026 |
| RBC Capital | Maintained | Outperform | $8.00 from $15.00 | Aug 6, 2026 |
| UBS | Maintained | Buy | $10.00 from $14.00 | Aug 6, 2026 |
| Truist Securities | Maintained | Buy | $9.00 from $14.00 | Aug 5, 2026 |
| Jefferies | Upgraded | Hold → Buy | $13.00 from $11.00 | Jul 21, 2026 |
| Baird | Maintained | Outperform | $15.00 from $18.00 | Jul 6, 2026 |
| RBC Capital | Maintained | Outperform | $15.00 from $13.00 | May 11, 2026 |
| UBS | Maintained | Buy | $14.00 from $15.00 | May 6, 2026 |
| Canaccord Genuity | Maintained | Buy | $16.00 from $14.00 | May 6, 2026 |
| Truist Securities | Maintained | Buy | $14.00 from $13.00 | Apr 13, 2026 |
| Leerink Partners | Maintained | Outperform | $12.00 from $13.00 | Feb 26, 2026 |
| Canaccord Genuity | Maintained | Buy | $15.00 from $14.00 | Nov 6, 2025 |
| Truist Securities | Maintained | Buy | $13.00 from $14.00 | May 12, 2025 |
| RBC Capital | Maintained | Outperform | $13.00 from $14.00 | May 8, 2025 |
| Baird | Maintained | Outperform | $16.00 from $14.00 | Feb 27, 2025 |
| Truist Securities | Maintained | Buy | $14.00 from $12.00 | Feb 26, 2025 |
| RBC Capital | Maintained | Outperform | $14.00 from $11.00 | Feb 26, 2025 |
| Canaccord Genuity | Maintained | Buy | $14.00 from $13.00 | Feb 26, 2025 |
| UBS | Maintained | Buy | $11.00 from $12.00 | Feb 13, 2025 |
| RBC Capital | Maintained | Outperform | $11.00 from $13.00 | Nov 19, 2024 |
Frequently asked questions
What is the price target for AHCO stock?
The average 12-month analyst price target for AdaptHealth (AHCO) is $9.80, with a high estimate of $13.00 and a low of $8.00, across 5 analysts.
Is AHCO a buy, sell, or hold?
Analysts covering AdaptHealth currently average a Buy rating: 7 buy, 0 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for AHCO?
The average price target of $9.80 implies 56.80% upside from the last price of $6.25.
What is the latest analyst rating on AHCO?
On Sep 17, 2026, Baird maintained AdaptHealth at Outperform with a price target of $9.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.